Home›Companies›Biotech & Pharma›Amphix Bio

Amphix Bio, Inc.

Updated Oct 29, 2026·Latest SEC filing Dec 19, 2025·Suggest an edit

About Amphix Bio

Amphix Bio is a private company based in Chicago, Illinois. It has reported $10,300,000 raised in one offering on Form D since December 2025. Its chief executive is Nicholas Sather.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 4, 2025Dec 19, 2025$10,300,000of $12.5M target9$1.1MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Amphix Bio's Form D filed Dec 19, 2025.

SS
Samuel Stupp
Executive officer and director
KW
Kok-Wai Wong
Director
SW
JP
NS
Nicholas Sather
CEO and director

Sources

  1. SECAmphix Bio, Inc. filing history